⌘K
OverviewStock screenerAnalyst actionsCalendar
MarketsInvestorsSign in
StockUnited StatesNYSE

MRK

Merck & Co., Inc.

Healthcare · Drug Manufacturers - General

147.53USD

-0.9300 (-0.63%)

DescriptionHistoricalFinancialsRelative ValueResearchNewsDiscussionOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.
Fiscal Year End12/2025
Last Quarter End06/2026 Q2
Current/T12M(USD)
1)

Issue Data

Last PxUSD / 147.53
P/E114.7
Dvd Ind Yld2.3%
P/B8.68
P/S5.5
Curr EV/T12M EBITDA14.3
Mkt Cap (USD)364.0B
Curr EV (USD)413.1B
2)

Per Share Data

EPS T12M1.24
DPS3.36
Bk Val Per Sh16.99
Rev/Sh26.95
Cash/Sh2.89
Curr Shares Out2,467.2M
FCF/Sh6.50
3)

Cash Flow Analysis

P/CF18.2
Curr P/FCF22.7
CF/NI6.3
Dvd P/O261.5%
Cash Gen/Cash Reqd1.6
Csh Dvd Cov2.4
CFO/Sales30.0%
Eff Interest Rate3.9%
4)

Growth Potential

Dil EPS 1Y Gr8.0%
Cap 1Y Gr22.2%
BPS 1Y Gr15.1%
R&D To Sales45.7%
Retention Rate-161.5%
Rev 1Y Gr1.3%
FCF 1Y Gr-31.7%
Assets 1Y Gr16.9%
5)

Profitability

EBITDA28.9B
EBIT—
Operating Margin-0.2%
Pretax Margin8.9%
Net Margin4.8%
ROA2.6%
ROE7.0%
ROC—
Asset Turnover0.54
6)

Structure

Current Ratio1.32
Quick Ratio0.74
Debt/Assets41.5%
Debt/Com Eq128.6%
Net Debt/EBITDA1.63
Tot Debt/Capital56.2%
Gross Margin73.0%
EBIT/Int Exp—

Returns and turnover use the AVERAGE balance over the year, not the closing snapshot. Growth rates compare the two most recent fiscal years.